What Is the Best Treatment for Lyme Disease?

When patients come to the office with Lyme disease, many have already been treated—yet they’re still sick. Others are newly diagnosed, overwhelmed by strange symptoms and uncertain about what lies ahead.

The question I hear most often is simple:

“What’s the best treatment?”

The answer is rarely one-size-fits-all.

---

Clinical Perspective

After treating Lyme disease for decades, I have found that some patients recover quickly while others continue to struggle with persistent symptoms.

Some individuals improve after a standard course of antibiotics. Others face delayed diagnosis, neurologic involvement, autonomic dysfunction, or overlapping co-infections that complicate recovery.

Important questions regarding persistent symptoms remain unanswered, and no currently available test can definitively determine whether infection has been completely eradicated.

Because Lyme disease affects individuals differently, treatment decisions are often based on symptoms, history, timing of illness, and response to therapy rather than a single laboratory result.

---

Why Early Treatment Matters

Patients diagnosed and treated early often recover more quickly and may be less likely to develop prolonged symptoms.

Delayed diagnosis can allow Lyme disease to affect the nervous system, joints, heart, or autonomic nervous system, making recovery more complicated.

Because early symptoms are frequently overlooked or mistaken for other illnesses, prompt recognition remains important.

---

Clinical Decision-Making in Lyme Disease

Effective treatment often depends on several factors:

• How long symptoms have been present
• Whether symptoms were recognized early or delayed for months
• Whether symptoms relapsed after prior treatment
• Whether co-infections such as Babesia or Bartonella may be involved
• Whether neurologic, cardiac, or autonomic symptoms are present

For some patients, a standard antibiotic course is sufficient.

Others may require:

• Longer treatment durations
• Use of multiple antibiotics, especially in neurologic Lyme disease
• Targeted treatment for co-infections
• Supportive care including probiotics, sleep support, anti-inflammatory strategies, and nutritional optimization

---

Why Treatment May Differ Between Patients

No single treatment plan works for everyone with Lyme disease.

Patients diagnosed early with a typical rash may recover with a standard antibiotic course, while those with delayed diagnosis, neurologic involvement, autonomic dysfunction, or co-infections may require more individualized management.

Age, immune function, symptom severity, prior treatment history, and associated conditions can all influence the treatment approach.

For this reason, Lyme disease management often involves ongoing reassessment rather than a one-time decision.

---

Is There a Strongest Antibiotic for Lyme Disease?

There is no single strongest antibiotic for Lyme disease.

Doxycycline is commonly used for early Lyme disease, while intravenous ceftriaxone may be considered for certain neurologic or cardiac manifestations.

The most appropriate treatment depends on the stage of illness, symptom pattern, co-infections, and individual response to therapy.

Because Lyme disease can affect multiple body systems, treatment decisions are often individualized rather than based on a single medication.

---

Common Antibiotics Used for Lyme Disease

The choice of antibiotics depends on disease stage, symptom pattern, affected systems, and individual response.

Common oral antibiotics include:

• Tetracyclines
  • Doxycycline
  • Minocycline (Minocin)
  • Tetracycline
• Beta-lactams
  • Amoxicillin
  • Penicillin VK
  • Cefuroxime (Ceftin)
  • Cefdinir (Omnicef)
• Macrolides
  • Azithromycin (Zithromax)
  • Clarithromycin (Biaxin)
  • Sometimes combined with hydroxychloroquine to enhance intracellular activity

Intravenous antibiotics used in more severe neurologic or cardiac Lyme disease may include:

• Ceftriaxone (Rocephin)
• Cefotaxime (Claforan)

---

Can Lyme Disease Treatment Make Symptoms Worse Before They Improve?

Some patients report a temporary worsening of symptoms after starting treatment, sometimes referred to as a Jarisch-Herxheimer reaction.

Symptoms may include increased fatigue, body aches, headaches, sweats, or worsening of existing symptoms.

Not every symptom flare represents a Herxheimer reaction, and worsening symptoms should always be discussed with a healthcare professional.

Learn more about the Jarisch-Herxheimer reaction.

---

Treating Co-Infections: Babesia and Bartonella

Babesia

Babesia is a malaria-like protozoan parasite that is not effectively treated with doxycycline.

Treatment commonly includes:

• Atovaquone (Mepron or Malarone)
• Combined with azithromycin (Zithromax)

Alternative regimens for more severe or relapsing cases may include artemisinin-based compounds or quinine-containing therapies.

Emerging therapies such as tafenoquine (Arakoda) have shown laboratory and animal-model activity against Babesia microti. Tafenoquine has been used off-label in select refractory or immunocompromised cases but remains under investigation.

Because tafenoquine can trigger hemolytic anemia in patients with G6PD deficiency, screening is required before use.

Bartonella

Bartonella is classically associated with cat scratch disease but is increasingly discussed as a possible co-infection in some patients with Lyme disease.

Because there are no universally accepted treatment guidelines for tick-associated Bartonella, some clinicians have adapted antibiotic approaches used for cat scratch disease and other Bartonella infections.

Common antibiotic families that may be considered include:

• Tetracyclines (doxycycline, minocycline)
• Macrolides (azithromycin, clarithromycin)
• Rifamycins (rifampin, rifabutin)
• Trimethoprim-sulfamethoxazole (Bactrim), typically as part of combination therapy

Physicians remain divided regarding the role of Bartonella in persistent tick-borne illness. Some clinicians consider Bartonella an important contributor to chronic symptoms, while others question its significance or whether tick transmission occurs.

As a result, treatment decisions are often individualized and based on the patient’s symptoms, history, and clinical response rather than on universally accepted protocols.

---

Persister-Directed Strategies

Laboratory studies suggest that Borrelia burgdorferi may adopt dormant or slow-growing forms that appear more tolerant to conventional antibiotics.

Feng and colleagues demonstrated that certain antibiotic combinations showed activity against these persister forms in vitro. These findings have stimulated interest in persister-directed therapies, although their clinical role remains uncertain.

Animal studies in rhesus macaques demonstrated persistence of Borrelia DNA and non-cultivable organisms after antibiotic treatment, though the significance of these findings in humans remains uncertain.

The role of persister forms in persistent Lyme symptoms continues to be actively investigated.

---

Approaches Targeting Biofilms

Laboratory studies have shown that Borrelia may form biofilm-like aggregates that could influence antibiotic susceptibility or immune responses.

This has led some clinicians to explore biofilm-disrupting therapies as adjunctive approaches.

Human evidence remains limited, and these strategies are generally considered investigational rather than established standards of care.

---

Treating the Whole Person

Lyme disease can affect multiple body systems and often requires more than antimicrobial treatment alone.

Emerging evidence suggests that dysautonomia may represent an important contributor to persistent symptoms in some patients with post-treatment Lyme disease syndrome.

• Neuropsychiatric symptoms — anxiety, depression, panic, insomnia, OCD
• Autonomic dysfunction — dizziness, rapid heartbeat, POTS, temperature dysregulation, adrenaline surges, sweats, and gastrointestinal motility problems
• Cognitive impairment — brain fog, memory issues, concentration difficulty
• Fatigue and post-exertional symptom worsening
• Muscle and joint pain
• Head pressure and migraines
• Light and sound sensitivity
• Vision changes or eye discomfort
• Tingling, numbness, or burning sensations
• Air hunger or shortness of breath
• Hormonal or menstrual changes
• Sleep disturbance
• Functional limitations affecting work, school, or social life

Successful care often depends on monitoring symptoms carefully, adjusting treatment when necessary, and supporting both physical and mental recovery.

---

What Do the Guidelines Say?

Some physicians follow a more standardized approach based on Infectious Diseases Society of America (IDSA) guidelines.

• 10–21 days of doxycycline for early Lyme disease
• Up to 28 days of IV ceftriaxone for neurologic or cardiac Lyme disease
• No additional antibiotics for persistent symptoms after standard therapy

Under this model, persistent symptoms are generally attributed to post-infectious immune or inflammatory changes rather than active ongoing infection.

This approach may work well for many individuals diagnosed and treated early.

However, patients with delayed diagnosis, relapsing illness, co-infections, or complex neurologic symptoms may require more individualized strategies.

---

What If Symptoms Persist After Lyme Disease Treatment?

Not everyone recovers after an initial course of antibiotics. Some patients continue to experience fatigue, pain, cognitive problems, dizziness, or autonomic symptoms despite treatment.

Persistent symptoms may reflect several factors, including delayed diagnosis, co-infections, immune dysregulation, autonomic dysfunction, or post-treatment Lyme disease syndrome.

In a small case series, patients developed postural orthostatic tachycardia syndrome (POTS) years after successful antibiotic treatment. Fatigue, cognitive dysfunction, palpitations, and orthostatic intolerance significantly affected daily functioning, though many improved with treatment directed at dysautonomia.

When symptoms persist, physicians may reassess the diagnosis, review prior treatments, consider overlapping conditions, and individualize management based on the patient’s clinical presentation.

Learn more about post-treatment Lyme disease syndrome and mechanisms proposed for persistent symptoms.

---

How Long Does Lyme Disease Treatment Take?

The duration of treatment varies depending on disease stage, symptoms, and individual response.

Some patients improve after a standard antibiotic course, while others with delayed diagnosis, neurologic involvement, or co-infections may require additional evaluation and more individualized management.

Recovery itself may continue long after antimicrobial therapy has ended.

---

Recovery Is Often Nonlinear

Recovery from Lyme disease is not always steady.

Patients frequently describe good days and bad days, temporary setbacks, and symptom fluctuations during the healing process.

Improvement may occur gradually rather than all at once.

Understanding that recovery is often nonlinear can help set realistic expectations and reduce unnecessary fear when symptoms temporarily flare.

---

Clinical Takeaway

The best treatment for Lyme disease is individualized.

Many patients recover with standard antibiotic therapy, particularly when diagnosed early. Others with delayed diagnosis, neurologic involvement, autonomic dysfunction, or co-infections may require broader evaluation and a more personalized approach.

Because Lyme disease affects multiple body systems, successful care often involves treating the whole person rather than focusing on a single symptom or laboratory result.

---

Frequently Asked Questions

What is the strongest antibiotic for Lyme disease?

There is no single strongest antibiotic for Lyme disease. Doxycycline is commonly used for early infection, while intravenous ceftriaxone may be used for certain neurologic or cardiac manifestations. Treatment decisions are based on the stage of illness, symptoms, co-infections, and individual response.

What is the best antibiotic for Lyme disease?

The best antibiotic depends on disease stage, symptom pattern, co-infections, and individual response. Doxycycline is commonly used early, but other antibiotics may be appropriate in different clinical settings.

Can Lyme disease require more than one antibiotic?

Yes. Some patients with neurologic symptoms or co-infections may receive combination therapy.

Does Lyme disease always respond to short-term treatment?

Many patients improve with standard treatment, particularly when diagnosed early. Others may experience persistent or relapsing symptoms requiring reassessment.

Can Lyme disease be cured?

Many patients recover completely, particularly when treatment begins early. Others experience persistent or relapsing symptoms that may require further evaluation and individualized management.

What is the role of co-infections in Lyme treatment?

Co-infections such as Babesia or Bartonella may alter symptom patterns and influence treatment choices.

Are biofilm or persister therapies proven treatments?

No. These approaches remain investigational and are still being studied.

---

References

1. Feng J, Auwaerter PG, Zhang Y. Drug combinations against Borrelia burgdorferi persisters in vitro: eradication achieved by using daptomycin, cefoperazone and doxycycline. PLoS One. 2015;10(3):e0117207.
2. Embers ME, Barthold SW, Borda JT, et al. Persistence of Borrelia burgdorferi in rhesus macaques following antibiotic treatment of disseminated infection. PLoS One. 2012;7(1):e29914.
3. Kanjwal K, Karabin B, Kanjwal Y, Grubb BP. Postural orthostatic tachycardia syndrome following Lyme disease. Cardiol J. 2011;18(1):63-66.
4. Adler BL, Chung T, Rowe PC, Aucott J. Dysautonomia following Lyme disease: a key component of post-treatment Lyme disease syndrome? Front Neurol. 2024;15:1344862.
5. Donta ST. What We Know and Don’t Know About Lyme Disease. Front Public Health. 2022;9:819541.

---

Dr. Daniel Cameron, MD, MPH
Lyme disease clinician with over 30 years of experience and past president of ILADS.

Symptoms • Testing • Coinfections • Recovery • Pediatric • Prevention